(Q35541583)

English

Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria

scientific article published on September 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria (English)

1 reference

Europe PubMed Central

8 August 2017

gram-positive bacteria

0 references

Gram-negative bacteria

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Whiting JL

1

1 reference

Europe PubMed Central

8 August 2017

Cheng N

2

1 reference

Europe PubMed Central

8 August 2017

Chow AW

3

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 September 1987

1 reference

Europe PubMed Central

8 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

8 August 2017

31

1 reference

Europe PubMed Central

8 August 2017

9

1 reference

Europe PubMed Central

8 August 2017

1379-1382

1 reference

Europe PubMed Central

8 August 2017

Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

The in vitro and in vivo activity of ciprofloxacin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Comparative activity of ciprofloxacin against anaerobic bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Tissue penetration of ciprofloxacin after single and multiple doses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

Comprehensive evaluation of ciprofloxacin-aminoglycoside combinations against Enterobacteriaceae and Pseudomonas aeruginosa strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

27 July 2018

In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174946

26 September 2018

Susceptibility of Legionella spp. to quinolone derivatives and related organic acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/3674848

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.31.9.1379

1 reference

Europe PubMed Central

8 August 2017

release_7wvkaiq3yvcbtbwuk6hsr6tacm

1 reference

https://api.fatcat.wiki/v0/release/7wvkaiq3yvcbtbwuk6hsr6tacm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35541583&oldid=1836129317"